Osborne Clarke advises naturalX Health Ventures on the funding round. naturalX Health Ventures, the venture capital arm of Schwabe Group, completed its investment in a Series A...
NaturalX Health Ventures (Schwabe Group)’s Investment in Mybacs
neoteq’s Investment in UGC Star-Up Speekly
Osborne Clarke has advised neoteq ventures on its investment. With the ever-growing marketing relevance of social media platforms, companies are increasingly focusing on advertising that is...
Sylphar NV and Karo Pharma AB’s Purchase of Satin Naturel
Osborne Clarke advised Sylphar NV and Karo Pharma AB on the deal. Sylphar NV and Karo Pharma AB purchased the Satin Naturel business from Del Decus...
Infosys’ Acquisition of Oddity
Osborne Clarke advised Indian IT group Infosys on the deal. Infosys acquired the German based digital agency Oddity. The purchase price for all shares in the...